Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • SOCIAL AND FINANCIAL BARRIERS TO OPTIMUM TKI TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA- A KNOWLEDGE-ATTITUDES-PRACTICES STUDY FROM INDIA

    Naveen Gupta, Manoranjan Mahapatra, Tulika Seth, Seema Tyagi, Sudha Sazawal, Renu Saxena
    e2021004
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.004
    1871
    PDF: 595
    HTML: 287
  • SEVERE LIVER IRON CONCENTRATIONS (LIC) IN 24 PATIENTS WITH ?-THALASSEMIA MAJOR: CORRELATIONS WITH SERUM FERRITIN, LIVER ENZYMES AND ENDOCRINE COMPLICATIONS

    Vincenzo De Sanctis
    e2018062
    2018-10-27
    https://doi.org/10.4084/mjhid.2018.062
    2775
    PDF: 1433
    HTML: 367
  • THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

    Vincenzo De Sanctis
    e2016058
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.058
    4298
    PDF: 1248
    HTML: 1323
  • VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE

    Ashraf Tawfik Soliman
    e2013057
    2013-09-02
    https://doi.org/10.4084/mjhid.2013.057
    2815
    PDF: 1111
    HTML: 2596
  • NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION

    Augustine Avilès
    e2015052
    2015-08-30
    https://doi.org/10.4084/mjhid.2015.052
    1824
    PDF: 1018
    HTML: 1835
    Tables: 195
  • EVOLVİNG PARADİGMS İN THE MANAGEMENT OF PRİMARY IMMUNE THROMBOCYTOPENİA İN ADULTS: FROM CORTİCOSTEROİDS TO TARGETED BİOLOGİC THERAPİES

    Massimo Martino, Laura Giordano, Maria Bruna Greve, Violetta Marafioti, Caterina Alati
    e2026067
    2026-09-01
    https://doi.org/10.4084/MJHID.2026.067
    0
    PDF: 0
    Html: 0
  • Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in a Child with Myelodysplastic Neoplasm with Complex Karyotype and ETV6 Variant: Challenges in Treatment

    Elaiza Almeida Antônio de Kós , Viviane Lamim Lovatel , Rita de Cássia Barbosa Tavares , Gerson Moura Ferreira , Bernadete Evangelho Gomes, Ana Paula Silva Bueno, Elaine Sobral da Costa , Teresa de Souza Fernandez
    e2024040
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.040
    902
    PDF: 999
    HTML: 99
  • THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA

    Luca Laurenti
    e2013027
    2013-04-10
    https://doi.org/10.4084/mjhid.2013.027
    2261
    PDF: 1063
    HTML: 2733
  • MOLECULAR MECHANISM OF TRAF6 IN MALIGNANT PROLIFERATION OF HUMAN NK/T CELL LYMPHOMA CELL HANK1

    Yan Qi, Chengbo Xu, Zesong Chen, Jiawei Chen, Congjie Chen
    e2025074
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.074
    597
    PDF: 325
    html: 129
  • BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

    Mario Biglietto, Rosaria Mormile, Maria Laura Bisegna, Alessandro Laganà, Anna Laura Faccini, Andrea Papa, Erminia Baldacci, Cristina Santoro, Maria Stefania De Propris, Antonio Chistolini
    e2025076
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.076
    457
    PDF: 230
    Html: 74
  • Human T-cell leukemia virus type ? associated with an increased risk of primary malignant neoplasm

    Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
    e2018024
    2018-04-20
    https://doi.org/10.4084/mjhid.2018.024
    2337
    PDF: 758
    HTML: 335
  • CLINICAL AND BIOCHEMICAL DATA OF ADULT THALASSEMIA MAJOR PATIENTS (TM) WITH MULTIPLE ENDOCRINE COMPLICATIONS (MEC) VERSUS TM PATIENTS WITH NORMAL ENDOCRINE FUNCTIONS: A RETROSPECTIVE LONG-TERM STUDY (40 YEARS) IN A TERTIARY CARE CENTER IN ITALY

    Vincenzo De Sanctis, Heba Elsedfy
    e2016022
    2016-04-12
    https://doi.org/10.4084/mjhid.2016.022
    4569
    PDF: 1063
    HTML: 3554
  • EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

    Ali Bay, Enes Coskun, serdar oztuzcu, sercan ergun, fatih yilmaz, elif aktekin
    e2013066
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.066
    1440
    PDF: 722
    HTML: 1185
    Untitled: 198
    Untitled: 162
    Untitled: 149
    Untitled: 167
    Untitled: 178
  • HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK

    Katleen de Gaetano Donati, Roberto Cauda, Licia Iacoviello
    e2010034
    2010-11-10
    https://doi.org/10.4084/mjhid.2010.034
    1927
    PDF: 822
    HTML: 3687
  • LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1

    kang sun
    e2024037
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.037
    2955
    PDF: 1135
    HTML: 127
  • SPECTRUM OF BETA GLOBIN GENE MUTATIONS IN EGYPTIAN CHILDREN WITH ?- THALASSEMIA

    MR El-Shanshory, Adel Abd Elhaleim Hagag
    e2014071
    2014-08-28
    https://doi.org/10.4084/mjhid.2014.071
    2114
    PDF: 1069
    HTML: 4285
  • THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML

    Dr. Palmieri, Ilaria Del Principe, Dr. Maurillo, Prof. Venditti, Francesco Buccisano
    e2023051
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.051
    1954
    PDF: 857
    HTML: 252
  • PREVALENCE AND AETIOLOGY OF BACTEREMIA IN FEBRILE CHILDREN WITH SICKLE CELL DISEASE AT A NIGERIA TERTIARY HOSPITAL

    Biobele Jotham Brown, Hannah O Dada-Adegbola, Catherine Trippe, Olufunmilayo Olopade
    e2017039
    2017-06-20
    https://doi.org/10.4084/mjhid.2017.039
    3034
    PDF: 1348
    HTML: 1101
  • Luspatercept Treatment in a β-Thalassemia Patient with Pulmonary Arterial Hypertension: A Case Report

    beibei yang, dongmei liu, changyu yang, Yali zhou, Guiping Liao, jian huang, Yingying Li, yinjiang tang, xiaolin yin
    e2025059
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.059
    1217
    PDF: 622
    Html: 168
  • CLINICAL CARE PATHWAY AND MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS: A MODIFIED DELPHI CONSENSUS FROM SAUDI ARABIA AND UAE

    Abdulrahman Al Raizah, Fakhr Alayoubi, Galal Hassan Abdelnaby, Hazzaa Alzahrani, Majid Farraj Bakheet, Mohammed A Alskaini, Rasha Buhumaid, Sameer Al Awadhi, Sara Nooruddin Kazim, Thiagarajan Jaiganesh, Zohair Al Asiri
    e2024038
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.038
    2632
    PDF: 1241
    HTML: 121
  • Increased mortality in male recipients of red cells from ever pregnant female donors : mHAGs on red cells to blame ?

    Kanjaksha Ghosh
    e2018009
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.009
    2864
    PDF: 673
    HTML: 413
  • TREOSULFAN-BASED CONDITIONING REGIMEN IN SIBLING AND ALTERNATIVE DONOR HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDREN WITH SICKLE CELL DISEASE

    Antonio Marzollo, Elisabetta Calore, Manuela Tumino, Marta Pillon, Maria Vittoria Gazzola, Roberta Destro, Raffaella Colombatti, Piero Marson, Tiziana Tison, Anna Colpo, Chiara Mainardi, Maria Gabelli, Maria Paola Boaro, Sara Rossin, Aurora Strano, Nadia Quaglia, Federica Menzato, Giuseppe Basso, Laura Sainati, Chiara Messina
    e2017014
    2017-02-15
    https://doi.org/10.4084/mjhid.2017.014
    4399
    PDF: 1572
    HTML: 1252
  • HOW I TREAT FEBRILE NEUTROPENIA

    Marcio Nucci
    e2021025
    2021-02-26
    https://doi.org/10.4084/mjhid.2021.025
    7070
    PDF: 4030
    HTML: 654
  • MOLECULAR MECHANISMS OF INHIBITOR DEVELOPMENT IN HEMOPHILIA Guest Editor: Giancarlo Costaman

    Davide Matino, Paul Tieu, Dr., Antony Chan
    e2020001
    2020-01-01
    https://doi.org/10.4084/mjhid.2020.001
    3467
    PDF: 1651
    HTML: 642
  • ADVANCES IN THE TREATMENT OF MALARIA

    Francesco Castelli, Lina Rachele Tomasoni, Alberto Matteelli
    e2012064
    2012-10-03
    https://doi.org/10.4084/mjhid.2012.064
    2912
    PDF: 1331
    HTML: 6140
  • Internal Medicine Ward with Hematological Skills for the Treatment of Complications Suffered by Hematological Patients on Therapy: Experience of Villa Betania Hospital inRome

    alessandro andriani, Laura Marchetti, Fabio Rossi, Silvia Raja, Maria Antonietta Perretti, Umberto Recine
    e2024030
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.030
    663
    PDF: 1064
    HTML: 100
  • THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis

    ANTONIO LEONE, SILVIA MACAGNINO, GIULIA D'AMBRA, DANIELE PERLA
    e2021056
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.056
    1617
    PDF: 586
    HTML: 872
  • SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE

    Nicola Semeraro, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci
    e2010024
    2010-08-06
    https://doi.org/10.4084/mjhid.2010.024
    3500
    PDF: 1843
    HTML: 4784
  • CLINICAL IMPACT OF ELTROMBOPAG-ASSOCIATED IRON CHELATION IN ADULTS WITH IMMUNE THROMBOCYTOPENIA: A MULTICENTER REAL-WORLD STUDY

    Ahmet Yigitbasi, Elif Gulsum Umit, Ufuk Demirci, Guray Aygun, Nese Varli, Elif Aksoy, Fehmi Hindilerden, Emine Gulturk, Eren Arslan Davulcu, Ahmet Muzaffer Demir
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.027
    900
    PDF: 802
    HTML: 155
  • CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab

    r. Salam Al-Kindi, Isra Al-Busaidi, Anil Pathare
    e2024046
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.046
    1387
    PDF: 1198
    HTML: 136
  • HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19

    Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando
    e2021011
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.011
    1702
    PDF: 625
    HTML: 283
  • IMMUNOLOGY OF TUBERCULOSIS

    Federica Bozzano, Francesco Marras, Andrea De Maria
    e2014027
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.027
    5654
    PDF: 2079
    HTML: 7356
    Untitled: 213
  • EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES

    Kjeld Schmiegelow
    e2011020
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.020
    2283
    PDF: 844
    HTML: 1696
    Figure 1: 218
    Table 1: 232
  • Acquired CD20 Loss as a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma

    Martina Canichella, Stefano Fratoni, Carla Mazzone, alice di rocco, elisabetta abruzzese
    e2026014
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.014
    955
    PDF: 755
    Html: 175
  • Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis

    Alessandro Laganà, Giovanni Manfredi Assanto, Mauro Passucci, Cristina Santoro, Antonio Chistolini
    e2024047
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.047
    1206
    PDF: 1023
    HTML: 95
  • THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM

    May Basood, Howard S. Oster, Moshe Mittelman
    e2018046
    2018-07-01
    https://doi.org/10.4084/mjhid.2018.046
    3292
    PDF: 1423
    HTML: 659
  • The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY

    Sarah Liptrott, Mairéad NíChonghaile, Liz O'Connell, Erik Aerts
    e2023033
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.033
    1994
    Suppl. Files: 916
    HTML: 580
    PDF: 782
  • GENE THERAPY IN THALASSEMIA AND HEMOGLOBINOPATHIES

    Laura Breda, Roberto Gambari, Stefano Rivella
    e2009008
    2009-11-16
    1356
    PDF: 437
    HTML: 3137
  • Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma

    Vincenzo Sammartano, Sara Ciofini, Beatrice Esposito Vangone, Chiara Carrara, Monica Bocchia, Alessandro Gozzetti
    e2025051
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.051
    787
    PDF: 612
    HTML: 51
  • TYROSINE KINASE INHIBITORS AND PREGNANCY

    Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo De Fabritiis, Alessio Pio Perrotti
    e2014028
    2014-04-07
    https://doi.org/10.4084/mjhid.2014.028
    3730
    PDF: 1707
    HTML: 2689
  • CHANGES OF VON WILLEBRAND FACTOR DURING PREGNANCY IN WOMEN WITHOUT AND WITH VON WILLEBRAND DISEASE

    Giancarlo Castaman
    e2013052
    2013-07-16
    https://doi.org/10.4084/mjhid.2013.052
    3245
    PDF: 1080
    HTML: 8583
  • Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

    Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team
    e2024043
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.043
    1340
    PDF: 982
    HTML: 95
  • THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA. ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS

    FASOLA ATINUKE
    e2022001
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.001
    2880
    PDF: 1028
    HTML: 90
  • APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS

    Rita Wilson Dib, Ray Hachem, Anne-Marie P Chaftari, Issam I Raad
    e2018028
    2018-05-01
    https://doi.org/10.4084/mjhid.2018.028
    2940
    PDF: 1141
    HTML: 454
    Preferred Reviewers: 226
  • Prevention of Early Death in Very Elderly Acute Promyelocytic Leukemia Patients Using Lower Induction Doses of All-trans Retinoic Acid

    Mark Dalgetty, Sruthi Dontu, Chandini Kannan, Amany Keruakous, Locke Bryan, Vamsi Kota, Anand Jillella
    e2025066
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.066
    988
    PDF: 665
    Html: 159
  • LEVOFLOXACIN PROPHYLAXIS VERSUS NO PROPHYLAXIS IN ACUTE MYELOID LEUKEMIA DURING POST-INDUCTION APLASIA: A SINGLE CENTER STUDY

    Irene Urbino, Chiara Frairia, Alessandro Busca, Silvia Corcione, Stefano D'Ardia, Chiara Maria Dellacasa, Valentina Giai, Carolina Secreto, Roberto Freilone, Francesco Giuseppe De Rosa, Semra Aydin, Giovannino Ciccone, Rosalba Rosato, Marco Cerrano, Ernesta Audisio
    e2023022
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.022
    1788
    PDF: 1128
    HTML: 419
  • Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.

    Salvatore Perrone, Chiara Lisi, Elettra Ortu La Barbera, Cristina Luise, Miriam Lichtner, Corrado Girmenia, Giuseppe Cimino
    e2020026
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.026
    1549
    PDF: 841
    HTML: 395
  • SUCCESSFUL LONG TERM ERADICATION OF FACTOR VIII INHIBITOR IN PATIENTS WITH ACQUIRED HAEMOPHILIA A IN SAUDI ARABIA

    Galila F Zaher, Soheir S Adam
    e2012021
    2012-04-02
    https://doi.org/10.4084/mjhid.2012.021
    1343
    PDF: 928
    HTML: 3621
  • Mantle cell lymphoma relapsing at the lymphedematous arm.

    Giuseppina Massini, Stefan Hohaus, Francesco D'Alo', Valentina Bozzoli, Barbara Vannata, Luigi Maria Larocca, Luciana Teofili
    e2013016
    2013-02-16
    https://doi.org/10.4084/mjhid.2013.016
    1744
    PDF: 716
    HTML: 3821
  • Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS

    Cengiz Bayram, Ali Fettah, Nese Yarali, Abdurrahman Kara, Fatih Mehmet Azik, Betül Tavil, Bahattin Tunc
    e2012018
    2012-03-13
    https://doi.org/10.4084/mjhid.2012.018
    1685
    PDF: 838
    HTML: 1238
351 - 400 of 500 items << < 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.